References
- Saboory E, Gholami M, Zare S, et al. The long‐term effects of neonatal morphine administration on the pentylenetetrazol seizure model in rats: the role of hippocampal cholinergic receptors in adulthood. Dev Psychobiol. 2014;56(3):498–509.
- Frenk H, Engel J, Ackermann RF, et al. Endogenous opioids may mediate post-ictal behavioral depression in amygdaloid-kindled rats. Brain Res. 1979;167(2):435–440.
- Velı́šek L, Velı́šková J, Moshé SL, et al. Prenatal morphine exposure alters ovarian steroid hormonal regulation of seizure susceptibility. Brain Res. 1998;796(1–2):247–256.
- Motevalian M, Mehrzadi S, Ahadi S, et al. Anticonvulsant activity of Dorema ammoniacum gum: evidence for the involvement of benzodiazepines and opioid receptors. Res Pharma Sci. 2017;12(1):53.
- Hemstapat K, Monteith GR, Smith D, et al. Morphine-3-glucuronide's neuro-excitatory effects are mediated via indirect activation of N-methyl-D-aspartic acid receptors: mechanistic studies in embryonic cultured hippocampal neurones. Anesth Analg. 2003;97(2):494–505.
- Khavandgar S, Homayoun H, Dehpour AR. The role of nitric oxide in the proconvulsant effect of δ-opioid agonist SNC80 in mice. Neurosci Lett. 2002;329(2):237–239.
- Homayoun H, Khavandgar S, Dehpour AR. The role of α2‐adrenoceptors in the modulatory effects of morphine on seizure susceptibility in mice. Epilepsia. 2002;43(8):797–804.
- Werz MA, MacDonald RL. Opiate alkaloids antagonize postsynaptic glycine and GABA responses: correlation with convulsant action. Brain Res. 1982;236(1):107–119.
- Frenk E. Malignant melanoma in a patient with severe psoriasis treated by oral methoxsalen photochemotherapy. Dermatology. 1983;167(3):152–154.
- Drake CT, Milner TA. Mu opioid receptors are in discrete hippocampal interneuron subpopulations. Hippocampus. 2002;12(2):119–136.
- Kalyuzhny AE, Dooyema J, Wessendorf MW. Opioid-and GABAA-receptors are co-expressed by neurons int the rat brain. Neuroreport. 2000;11(12):2625–2628.
- Panahi Y, Saboory E, Rassouli A, et al. The effect of selective opioid receptor agonists and antagonists on epileptiform activity in morphine-dependent infant mice hippocampal slices. Int J Dev Neurosci. 2017;60(1):56–62.
- Saboory E, Derchansky M, Ismaili M, et al. Mechanisms of morphine enhancement of spontaneous seizure activity. Anesth Analg. 2007;105(6):1729–1735.
- Honar H, Riazi K, Homayoun H, et al. Ultra-low dose naltrexone potentiates the anticonvulsant effect of low dose morphine on clonic seizures. Neuroscience. 2004;129(3):733–742.
- Cortez MA, Perez Velazquez JL, Snead OC. Animal models of epilepsy and progressive effects of seizures. Adv Neurol. 2006;97:293–304.
- Dorandeu F. Ketamine for the treatment of (super) refractory status epilepticus? Not quite yet. London (UK): Taylor & Francis; 2017.
- Wang C-Y, Hung C-H, Lin C-S, et al. Differential alterations of GABAA receptor (α1, β2, γ2 subunit) expression and increased seizure susceptibility in rat offspring from morphine-addicted mothers: Beneficial effect of dextromethorphan. Neurosci Lett. 2011;489(1):5–9.
- Gholami M, Saboory E, Roshan-Milani S. Proconvulsant effects of tramadol and morphine on pentylenetetrazol-induced seizures in adult rats using different routes of administration. Epilepsy Behav. 2014;36:90–96.
- Calabrese EJ. Modulation of the epileptic seizure threshold: implications of biphasic dose responses. Crit Rev Toxicol. 2008;38(6):543–556.
- Palizvan M, Ghaznavi-Rad E. Naloxone enhanced the inhibitory effect of verapamil on seizure induced by pentylenetetrazol in male rats. Res Pharma Sci. 2014;9(4):295.
- Peciña M, Karp JF, Mathew S, et al. Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches. Mol Psychiatry. 2019;24(4):576–587.
- Binder DK, Steinhäuser C. Functional changes in astroglial cells in epilepsy. Glia. 2006;54(5):358–368.
- Vaughan CW, Bagley EE, Drew GM, et al. Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR‐1. Br J Pharmacol. 2003;139(2):362–367.
- Deeb TZ, Maguire J, Moss SJ. Possible alterations in GABAA receptor signaling that underlie benzodiazepine‐resistant seizures. Epilepsia. 2012;53:79–88.
- Aram JA, Martin D, Tomczyk M, et al. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands. J Pharmacol Exp Ther. 1989;248(1):320–328.
- Rosati A, L'Erario M, Ilvento L, et al. Efficacy and safety of ketamine in refractory status epilepticus in children. Neurology. 2012;79(24):2355–2358.
- Zieglgansberger W, French E, Siggins G, et al. Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science. 1979;205(4404):415–417.
- Liu B, Hong J-S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther. 2003;304(1):1–7.
- Stach R, Przewłocki R, Kacz D. The effect of naloxone on carbachol-induced seizures in the caudate nucleus and in the hippocampus. Pol J Pharmacol Pharm. 1983;35(3):217–222.
- Ostermeier AM, Schlösser B, Schwender D, et al. Activation of μ-and δ-opioid receptors causes presynaptic inhibition of glutamatergic excitation in neocortical neurons. Anesthesiology. 2000;93(4):1053–1063.
- Martin G, Nie Z, Siggins GR. μ-Opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons. J Neurosci. 1997;17(1):11–22.
- Harris KD, Henze DA, Csicsvari J, et al. Accuracy of tetrode spike separation as determined by simultaneous intracellular and extracellular measurements. J Neurophysiol. 2000;84(1):401–414.